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ABSTRACT 
Oral tolerance (OT) towards antigens encountered in the gut is a vital immune function of gut immunity. Experi-
mental models can demonstrate OT efficacy by feeding of a protein followed by peripheral immunization and 
measuring the specific antibody titer. We had previously shown that exposure to 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD), a xenobiotic high-affinity aryl hydrocarbon receptor (AhR)-ligand, destabilized OT against oval-
bumin (OVA) in mice. AhR is involved in the development, differentiation and function of immune cells, and 
highly expressed in gut epithelial cells and gut immune cells. We here used AhR-deficient mice to study the role 
of AhR in OT further. We show that complete AhR-deficiency undermines the stability of oral tolerance against 
OVA upon multiple immunizations, despite no renewed oral encounter with the antigen. This OT destabilization 
is accompanied by significant changes in IL10 and TGF RNA in the gut tissue. Using conditional AhR-deficient 
mouse lines, we identify T cells as the major responsible immune cell type in this context. Our findings add to 
knowledge that lack of AhR signaling in the gut impairs important gut immune functions.  
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INTRODUCTION 
The immune system is vital to fight off 
pathogens and cancer cells. Dendritic cells 
(DC) and other antigen-presenting cells take 
up and proteins, present them as peptides on 
their cell surface in order to guide and instruct 
T cells, which recognize peptide antigens by 
their specific T cell receptor. An important 
and unique feature of the immune system is 
the distinction between (i) foreign and auto-
antigens, and (ii) between harmless and harm-
ful antigens (Matzinger, 1994; Pradeu and 
Cooper, 2012). While all proteins are poten-
tial antigens, immune responses are normally 
not raised against one´s own body proteins, 
and in general only against pathogens. The 
underlying mechanisms are very complex and 
under intense investigation, as failure to make 
this distinction, and thus not to become toler-
ant – using the immunological term – against 
harmless antigens can cause debilitating auto-
immune diseases or allergies, sometimes even 
death. Immunologic memory ensures that tol-
erance, once established, remains sustained, 
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even during long stretches of not encounter-
ing again the original tolerizing antigen 
(Siewert et al., 2008; Pabst and Mowat, 2012; 
Cheroutre and Madakamutil, 2005).  
The aryl hydrocarbon receptor (AhR), an 
evolutionary old ligand-activated transcrip-
tion factor, is highly expressed in the intesti-
nal epithelium and in many immune cells. 
Much evidence in the last years delineated a 
critical role for AhR in balancing inflamma-
tory versus regulatory immune responses, 
e.g., by shifting T cell differentiation towards 
regulatory T cells, or instructing DC towards 
a tolerance-inducing phenotype. AhR links 
the environment to the immune system. In-
deed, AhR may have evolved (or maybe hi-
jacked during evolution) to be part of the im-
mune system´s strategies to moderate im-
mune responses by using natural or endoge-
nous indoles, tryptophan derivatives, glucos-
inolates and other small molecular weight 
chemicals (Hubbard et al., 2016; Soshilov and 
Denison, 2014; Bessede et al., 2014; Denison 
et al., 2011). Genetic ablation of AhR in mice 
affects gut immunity, e.g., mice become more 
susceptible to Citrobacter rodentium infec-
tion, their gut microbiome changes, and the 
mice have a higher bacterial load in general 
(Li et al., 2011; Kiss et al., 2011; Murray et 
al., 2016). Evidence regarding the skin and 
the gut suggests strongly that a certain amount 
of AhR-induction by dietary ligands is neces-
sary for health; certain plants can provide 
such ligands (Haas et al., 2016; Esser and 
Rannug, 2015; Haarmann-Stemmann et al., 
2015). Oral tolerance (OT) is the term for the 
vital immunological phenomenon that no im-
mune responses are made against antigens en-
countered via the oral route. OT has been de-
scribed many decades ago. In mice, it is usu-
ally modeled by feeding of protein antigens 
(such as ovalbumin (OVA) or keyhole limpet 
hemocyanin), followed by immunization with 
the antigen (Weiner et al., 2011; Pabst and 
Mowat, 2012). Subsequently, either for-
mation of antibodies is measured in the se-
rum, or the capacity for T cell restimulation 
detected in vitro. It is still under debate 
whether antigen dose directs the underlying 
mechanisms such as T cell anergy and/or the 
increase of regulatory T cells (Treg). The 
main mechanisms of OT, starting with anti-
gen sampling from the gut by CD103+DC, 
Treg generation in mesenteric lymph nodes, 
and homing of Treg back to the lamina pro-
pria have been clarified. OT against food an-
tigens is both local and systemic, and must be 
distinguished from local tolerance against gut 
residing commensal bacteria. Food allergies 
and celiac disease are thought to result from 
impaired OT induction (Burks et al., 2008; 
Makharia, 2014)  
We had previously shown that persistent 
activation of the AhR by the high-affinity xe-
nobiotic ligand 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) can break OT. Thus, TCDD-
treated mice produced antibodies against the 
model antigen OVA after several boosting 
immunizations, despite previous tolerization 
(Chmill et al., 2010). Our data in this study 
had suggested a DC-driven shift in the 
Treg/Th17 balance. To clarify the role of AhR 
in OT further, we here analyze AhR-deficient 
mice for stabile OT. Our data show that AhR 
is not critical for the establishment of OT, but 
contributes to its stability. AhR-expressing 
adaptive T cells are a major responsible cell 
population, indicating a role of AhR in estab-
lishing memory for OT.  
 
MATERIAL AND METHODS 
Mice  
We used AhR-deficient mice (Schmidt et 
al., 1996) or conditional AhRlck, AhR∆CD11c, 
and AhR∆villin mice, which we bred by cross-
ing AhRflox/flox mice (Walisser et al., 2005) 
with mice, which expressed Cre-recombinase 
under the respective promoter (CD11c-Cre 
(Caton et al., 2007), Villin-Cre (Madison et 
al., 2002), lck-Cre (Hennet et al., 1995)). 
Mice were tested for successful conditional 
deletion. We sorted target cells (for instance 
the intestinal epithelial cells for AhR∆villin) 
and various organ tissues, which do not con-
tain the target cells, such as liver, thymus, B 
cells etc.) and analyzed for the ahr deletion by 
PCR. As known from the original publication, 
the CD11c-Cre mice deleted the ahr gene also 
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in a minor fraction of T cells. In AhRlck, ahr 
was not efficiently deleted in gut  T cells, 
and consequently, these mice had the same 
frequency ofT cells than wild-type litter-
mates. All other T cells deleted ahr in this 
line. For all mouse lines we used the line-spe-
cific wild-type littermates as controls. Mice 
were bred in our specific-pathogen free ani-
mal facility; mice were under a 12 hour/12 
hour light–dark cycle, and had access to food 
and water ad libitum. 
All experiments were done after obtaining 
permission of the relevant governmental bod-
ies, in accordance with relevant German ani-
mal welfare laws.  
 
OT induction  
For tolerization, mice were gavaged with 
20 mg OVA (grade V;#A5503, Sigma-Al-
drich, Munich, Germany) in PBS/20 g body 
weight on day 0, day 2, and day 5 of the ex-
periment. Mice were then immunized i.p. day 
12 with 10 µg OVA in Complete Freund´s ad-
juvant (CFA) and boosted on days 26, 33 and 
40 with 10 µgOVA/20g body weight, dis-
solved in incomplete Freund´s adjuvant 
(IFA). In contrast to other protocols with low 
and medium dosage (e.g. 20 mg once or 
0.5 mg OVA five times), which we tested in 
preliminary experiments, this high-dose toler-
ization protocol induced a stable tolerance 
upon several re-challenges. Serum samples 
were taken on the days of immunization.  
 
OVA-ELISA 
OVA-specific IgG1 antibodies in mouse 
serum were determined by ELISA. 96-well 
plates were coated with 100 µg/ml OVA 
overnight at 4 °C. Serum samples were ti-
trated onto the plates and detected with goat 
anti-mouse IgG1 antiserum (Southern Bio-
tech, Birmingham, USA) coupled to biotin. 
The ELISA was developed with avidin-
HRP/TMB and values measured at 450 nm 
after addition of 0.75 µl H2SO4. All values are 
expressed relative to a standard from pooled 
sera of C57BL/6 mice immunized and 
boosted with OVA/IFA.  
 
Flow cytometry of intraepithelial 
lymphocytes and lamina propria cells  
For isolation of immune cells from the in-
testinal epithelial cells and the lamina propria, 
the small intestine was resected, washed and 
cut into small pieces. For IEL, the pieces were 
placed in a PBS/10 % FCS/2mM EDTA solu-
tion for 30 min at 37° C in a shaking water 
bath. The solution was passed through a 
strainer and stored on ice for immediate stain-
ing. For isolation of lamina propria cells the 
epithelial-depleted residual intestinal tissue 
was placed for 20 minutes in a solution con-
taining 0.15 mg/ml collagenase-P and 
0.025 mg/ml DNAse-I (Roche, Mannheim, 
Germany). The solution was vigorously vor-
texed and then filtered through a 100 µm 
strainer. Lymphocytes/ leucocytes were then 
isolated on an EasyColl™ density gradient 
(Biochrome, Berlin, Germany), and immedi-
ately stained with fluorescently labeled anti-
bodies. Fc receptors were blocked with 
CD16/32 (BioLegend, Fell, Germany). Dead 
cells were discriminated using Fixable Viabil-
ity Dye eFluor 506 (eBioscience, Frank-
furt/Main, Germany). Cells were analyzed in 
list-mode on a FACSCanto-II™ flow cytom-
eter (Becton-Dickinson, Heidelberg, Ger-
many). Live lymphocytes/leucocytes were 
gated according to scatter characteristics. An-
tibodies were: MHC-II (M5/ 114.15.2 BD-Bi-
osciences, Heidelberg, Germany), CD11c 
(N418), CD103 (2E7, eBioscience, Frankfurt, 
Germany), CD3e (145-2C11; BioLegend, 
Fell, Germany), pan anti GL3 BioLegend, 
Fell)  
 
RT-PCR 
Small intestine pieces were stored at  
-80 °C. Tissue was homogenized in 
RNAmagic (BioBudget, Krefeld, Germany). 
RNA was extracted and reversely transcribed 
into cDNA. Quantitative reverse transcription 
PCR reactions were done with the Rotor-
Gene SYBR Green PCR Kit (Qiagen, Hilden, 
Germany) in a Rotor-GeneQ thermo cycler 
(Qiagen, Hilden, Germany). The following 
primers were used:  
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GAPDH-F 5’-CGTCCCGTAGA-
CAAAATGGT-3’,  
GAPDH-R 5’-TTGATGG-
CAACAATCTCCAC-3’,  
KGF-F 5´-CAAAGGGGTGGAAAGTGAA-
TAC-3´,  
KGF-R 5´-GGAATCCCCTTTTGAT-
TTAAGG-3´;  
FGR2IIIB-F 5´-TGGAGTTTGTCTG-
CAAGGTTTA-3´;  
FGR2IIIb-R 5´-GTTGGCCTGCCCTATA-
TAATTG-3´;  
GMSF-F 5´-CACAGTCCGTTTCCG-
GAGTT-3´:  
GMSF-R 5´-GGGTCTACGGGG-
CAATTTCA-3´;  
IL6-F 5´- TCCAATGCTCTCCTAACAGA-
TAAG-3´,  
IL6-R 5´-CAAGATGAATT-
GGATGGTCTTG-3´;  
IL10-F 5´-GGTTGCCAA-
GCCTTATCGGA-3´,  
IL10-R 5´-ACCTGCTCCACTGCCTTGCT-
3;  
TGF-R 5´-CACTGATACGCCTGAGTG-
3´,  
TGF-R 5´-GTGAGCGCTGAATCGAAA-
3´.  
Expression levels were calibrated to the ex-
pression of GAPDH in the same sample using 
the 2-CT method (Livak and Schmittgen, 
2001). 
 
Statistical methods 
Data were analyzed with GraphPad 
Prism™ using student´s t-test. Levels of sig-
nificance are indicated as  
* = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001, 
**** = P ≤ 0.0001. 
 
RESULTS 
Changes in intestine-associated immune 
cells and cytokine profile in AhR-deficient 
mice 
We analyzed the frequency of innate and 
adaptive T cells, CD103+ DC, and the inflam-
matory cytokines IL10, IL6, and TGF in the 
small intestine of naïve AhR-deficient mice. 
In addition we analyzed RNA expression of 
components of the GM-CSF-pathway. GM-
CSF promotes the production of retinoic acid 
by dendritic cells and expression of FoxP3 in 
regulatory T cells, thus is a pro-tolerogenic 
cytokine. The production of GM-CSF in turn 
is triggered by KGF, a product of  T cells 
(Yokota et al., 2009; Chen et al., 2002). The 
results are summarized in Table 1 and 2.  
As expected from previously published 
work, the gut T cells were strongly reduced 
in the AhR-deficient mice. In contrast, lamina 
propria DCs increased. An increase in the 
CD103+ subset therein was not significant 
(P = 0.167). In two independent experiments 
comparing AhR-deficient mice and their 
wild-type littermates we did not find differ-
ences between the frequencies of 
DC/CD103+ subset in the mesenteric lymph 
nodes, nor for CD4+, CD+ FoxP3+ (i.e. regu-
latory T cells) or CD4+IL17+ (Th17) T cells 
in the lamina propria or the mesenteric lymph 
nodes (data not shown).  
Together, the data confirm and extend 
data showing that in naïve AhR-deficient 
mice the frequency of intestinal  T cells is 
reduced and DCs are skewed (Li et al., 2011; 
Kiss et al., 2011). We did not detect differ-
ences in genes KGF and the downstream-as-
sociated pathway genes Fgr2IIIB or GM-CSF 
in whole tissue extracts. For GM-CSF we also 
analyzed supernatants of 4 h ex vivo culti-
vated tissues, but again we did not detect dif-
ferences between AhR-deficient mice and 
their WT littermates (data not shown). How-
ever, the gene expression of the regulatory cy-
tokine IL10 was significantly reduced in jeju-
num and ileum of AhR-deficient mice. The 
pleotropic pro-inflammatory cytokine IL6, 
which may be involved both in intestinal in-
tegrity and in the Treg/Th17 balance (Bettelli 
et al., 2006), was reduced as well, albeit only 
slightly and not across the entire intestine (Ta-
ble 2). 
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Table 1: Frequency of T cells and dendritic cells in the intestinal epithelium and lamina propria of AhR-
deficient mice and WT littermates 
 CD3+ T cells in IELa γδT cells thereofa DC in LPb CD103+DC thereofb
WT 45.4 % ± 10.4 % 41.8 % ± 11.2 % 0.96 % ± 0.25 % 65.5 % ± 15.7 % 
AhR-KO 49.5 % ± 6.6 % 16.0 % ± 5.6 % *** 2.32 % ± 0.52 % ** 80.6 % ± 2.73 % 
a Intestinal epithelial cells (IEL) cells were isolated from the small intestine and analyzed flow cytometrically for CD3+ cells 
and the γδ+ T cell subset (in IEL). 
b Lamina propria (LP) cells were isolated from the small intestine and analyzed flow cytometrically CD11c+MHCII+ dendritic 
cells (DC) and the CD103+ subpopulation therein.  
Shown are the percentages after gating on living cells/scatter characteristics. Mean±SD, significance of the difference be-
tween WT and AhR-deficient mice by student´s t-test; significance indicated in bold; **P ≤ 0.01; *** P ≤ 0.001. n = 4 
 
 
Table 2: Gene expression in the small intestine 
 KGFa GM-CSFa Fgr2IIIBa IL10a TGFβa IL6a 
WT 
Duo 0.32 ± 0.2 32.6 ± 10.7 8.08 ± 2.93 5.45 ± 3.3 15.6 ± 2.46 0.85 ± 0.12 
Jej 0.38 ± 0.05 85.8 ± 26.9 9.86 ± 3.09 9.46 ± 4.88* 11.7 ± 1.45 0.7 ± 0.16 
Ile 2.55 ± 1.28 3.15 ± 2.01 33.5 ± 6.94 10.5 ± 4.18* 12.4 ± 2.13 0.48 ± 0.07 
AhR-
KO 
Duo 0.12 ± 0.08 49.6 ± 8.56 7.61 ± 4.85 1.5 ± 0.32* 15.7 ± 4.63 0.4 ± 0.13* 
Jej 0.25 ± 0.14 78.5 ± 17.5 8.73 ± 3.54 3.23 ± 1.23* 8.63 ± 1.47* 0.25 ± 0.04**
Ile 1.68 ± 0.2 6.44 ± 2.63 27.8 ± 5.56 4.17 ± 2.7 10.8 ± 3.95 0.45 ± 0.24 
a relative expression against housekeeping gene GAPDH. RNA was isolated and transcribed into cDNA, from the total tissue of 
duodenal (Duo), jejunal (Jej) and ileal (Ile) sections of the small intestine. Real time PCR was performed for individual mice as 
described in Material and Methods. Mean ± SD, significance of the difference between WT and AhR-deficient mice by student´s 
t-test, *P ≤ 0.05; **P ≤ 0.01; *** P ≤ 0.001; significant numbers indicated in bold type. N = 3-4 mice  
 
 
AhR-deficient mice cannot sustain OT 
Stability of OT is an important feature of 
this vital immune function. We therefore 
tested in preliminary experiments how differ-
ent feeding protocols affect OT stability upon 
multiple boosts with the antigen. We immun-
ized up to four times within 47 days after ini-
tial OT induction with either 5x0.5 mg OVA, 
1x20 mg OVA, or 3x20 mg OVA. Only in the 
latter dosing scheme, tolerance was sustained, 
i.e. no increase in antibodies against OVA 
was detectable in serum after the last immun-
ization. In both the 5x0.5 mg OVA and 
1x20 mg OVA protocol anti-OVA antibody 
levels rose in the serum already upon the sec-
ond immunization (i.e. first boosting) (data 
not shown). We therefore used the feeding 
scheme of 3x20 mg OVA in the experiments 
whose results are described below.  
To analyze how AhR-deficiency affects 
the stability of OT, AhR-deficient mice and 
their wild-type littermates were tolerized with 
OVA, then immunized with OVA/CFA and 
boosted three times with OVA/IFA as de-
scribed in material and methods. The serum 
titers of anti-OVA antibodies were deter-
mined one week after the last boost, i.e. 47 
days after start of the experiment. The result 
is shown in Figure 1.  
There was no significant impairment in 
the capacity to generate a normal antibody re-
sponse in AhR-deficient mice as such (left 
side, PBS groups). Wild-type mice sustained 
OT over three boosts. However, AhR-defi-
cient mice showed a moderate, but significant 
increase in anti-OVA antibodies in their se-
rum (right side of graph). In other words, tol-
erance was induced but was not stable after 
several boosting. We note though, that in 
three out of eight AhR-deficient mice of the 
OVA group, no antibodies were produced, i.e. 
these mice sustained tolerance.  
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Figure 1: OT stability in AhR-deficient mice. Mice 
were tolerized orally (3x20 mg OVA i.g.), immun-
ized and then boosted 3 times. One week after the 
last boost, serum samples were taken and anti-
OVA antibodies determined relative to a standard. 
Black circles or squares: Wild type (Wt) mice, 
white circles or squares: AhR-deficient (Ko) mice. 
Each dot depicts the titer from an individual 
mouse. Data are pooled from three independent 
experiments. Left side of graph shows results for 
mice, which had not been tolerized against OVA, 
but which had been mock gavaged with PBS. Val-
ues relative to the mean of the WT PBS group 
(= 100 %) are shown. *P ≤ 0.05 by student’s t-
test.  
 
Deletion of AhR in T cells, but not intesti-
nal epithelial cells or CD11c+DCs, results 
in loss of OT 
The AhR is abundantly expressed in both 
the intestinal epithelial cells and several im-
mune cells of the gut (Esser and Rannug, 
2015). AhR-expression, or rather the lack 
thereof, may affect gut barrier integrity, pos-
sibly increasing antigen uptake or leakage. 
Regarding the immune cells, tolerogenicity 
might be affected, or cytokine production, 
which may affect the barrier (Ishikawa, 2009; 
Li et al., 2011; Brandstätter et al., 2016). We 
therefore ablated AhR cell-specifically in or-
der to identify the cell type relevant for OT 
destabilization. The results are shown in Fig-
ure 2.  
While OT remained stable if AhR was ab-
lated in either the intestinal epithelial cells or 
the dendritic cells (Figure 2 villin and 
CD11c), it was significantly broken in lck 
mice. Lck is part of the T cell receptor com-
plex, and it is expressed in all T cells. An ex-
ception may be the tissue specific invariant  
T cells, which develop only in the fetal
 
 
 
Figure 2: Stability of OT in conditional AhR-deficient mice. Mice deficient for AhR in intestinal epithelial 
cells (villin), dendritic cells (CD11c) or T cells (lck) were tolerized (3x20 mg OVA), immunized and 
then boosted 3 times [labeled as OVA in the graph]. As control, mice were fed PBS only [labeled as 
PBS in the graph]. One week after the last boost, serum samples were taken and anti-OVA antibodies 
determined relative to a standard. Black circles: Wild-type littermate mice (C), white circles: conditional 
AhR-deficient mice. Each dot depicts an individual mouse. Values relative to the mean of the respective 
littermate wild-type PBS group (= 100 %) are shown. *P ≤ 0.05 by student’s t-test.  
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thymus during short time-windows. These  
T cells home to their target tissue where they 
are maintained by homeostatic proliferation. 
We found that the frequency of T cells in 
the gut of lck mice was the same as in their 
wild-type littermates (34.1 % ± 9.6 % vs 
32.1 % ± 8.3 %, P = 0.772), and were not lost 
(as in fully AhR-deficient mice). However, in 
all conditional mouse lines, anti-OVA titers 
upon tolerization were still much lower than 
in the untolerized PBS groups. Note that also 
in the tolerized wild-type groups, some anti-
OVA antibodies were detectable, indicating 
that even in these mice immunizations led to 
a minor destabilization of tolerance.  
 
DISCUSSION 
Food contains numerous proteins 
(> 100 g protein per day in an average human 
diet), which are potential antigens and are im-
munogenic if encountered under immunizing 
conditions. Yet, we normally do not react to 
food antigens (Husby et al., 1994; Kapp et al., 
2010). It is generally assumed that this immu-
nological unresponsiveness to food antigens 
results from oral tolerance. Food allergies are 
highly prevalent, often lead to the so-called 
atopic march, and their treatment puts a high 
burden on patients and/or the health system. 
In this light it is important to better understand 
OT, as the immunological mechanism that 
may go wrong in the first place. Also, such 
knowledge can help inform therapies based 
on oral desensitization after a food allergy has 
occurred. Consequently, experimental models 
of OT in laboratory animals were developed 
in order to elucidate the underlying mecha-
nisms. 
In this paper we provide evidence that the 
AhR is a player in ensuring continuous oral 
tolerance against the dietary antigen OVA, 
even after longer periods of no renewed oral 
antigen encounter. Second, our data using 
conditional AhR-deficient mouse lines indi-
cated that primarily AhR expression in CD4+ 
T cells, but most likely not in gut-associated 
T cells, is critical for this outcome.  
Models of experimental OT in animals 
suggested that the dose and feeding regimes 
can influence which tolerizing mechanism is 
triggered, i.e. either induction of regulatory T 
cells or induction of T cell anergy (Friedman 
and Weiner, 1994; Faria and Weiner, 2005; 
Weiner et al., 2011; Weiner et al., 2011). This 
view has been challenged recently (Pabst and 
Mowat, 2012), and possibly both mechanisms 
occur side-by-side in a real-life situation. 
There may also exist a “no observed effect 
level” dose, i.e. when food antigens are too 
rare to necessitate an active OT response. 
Memory is an intrinsic feature of immune re-
sponses and memory T cells are long-lasting. 
This includes memory Treg cells, whose ho-
meostasis likely is regulated by MHC-II and 
CTLA-4 contact (Holt et al., 2017). Most 
models of experimental OT described in the 
literature look at tolerance induction after one 
immunization and one boost injection directly 
following tolerization, and thus do not test for 
long-term stability of tolerance, i.e. immune 
memory. One study (Oliveira et al., 2015) 
tested for persistence of OT by a single feed-
ing of 20 mg OVA i.g., followed with immun-
izing/boosting 90 days later. In this scenario, 
the anti-OVA titer was significantly lower 
than the controls, but present (appr. 50 % of 
PBS-fed controls), suggesting a slow loss of 
tolerance over time. Confirming and extend-
ing this result, we found that several boosts 
indeed break tolerance in low- and medium-
dose feeding protocols. In contrast, in our 
model of high-dose feeding (3 x 20 mg i.g.) 
“tolerance memory” persisted. Only when 
AhR was absent, tolerance slowly became de-
stabilized and antibodies against OVA detect-
able. However, the response was weak com-
pared to untolerized mice, i.e., the antibody ti-
ters were much lower. It is not easy to say 
whether there is an antibody threshold for 
causing or contributing to food allergy caused 
by a break of oral tolerance. This is a general 
shortcoming of experimental OT models, as 
the direct link to food allergy - whether of the 
IgG or IgE mediated type - is not part of the 
models. Nonetheless, given that oral desensi-
tization strategies are a method of choice for 
an existing food allergy, the link is convinc-
ing, both theoretically and practically. Of note 
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though, desensitization, i.e. a re-tolerization 
after an immune response has been estab-
lished and the damage is done, might entail 
different mechanisms than the establishment 
of tolerance upon first antigen encounter. Re-
garding a correlation between antibody titers 
and allergy, in human food allergies, even at 
very low specific IgE levels a food challenge 
test may be passed, suggesting that even low 
amounts of antibodies can lead to an allergic 
reaction to food (Perry et al., 2004). In con-
trast, in patients with irritable bowel syn-
drome, no correlation between symptoms and 
anti-food antigen-specific IgG was detected. 
The situation may be more complex, as 
demonstrated by a study in mice by Burton 
and colleagues (2014). They found that spe-
cific IgG antibodies, which were induced 
upon an oral desensitization protocol, pro-
tected from anaphylaxis, even when specific 
IgE was high. This was mediated by an IgG 
FcRIIB interaction. 
The loss of intraepithelial T cell fre-
quency in the gut is one of the striking find-
ings in the gut-associated lymphoid tissue of 
AhR-deficient mice (note that such a loss oc-
curs also in the skin (Kadow et al., 2011; Li et 
al., 2011)). T cells are innate immune cells, 
which are not MHC-restricted like T cells. 
They have several functions, in particular a 
first-pass and speedy cytokine secretion upon 
antigen contact. T cells also secrete factors, 
which strengthen the tight junctions and intra-
cellular adhesion of the epithelial cells 
(Vantourout and Hayday, 2013; Lee et al., 
2015). Reflecting the decrease in  T cell fre-
quency, we detected less RNA for IL10, 
TGF and IL6 in the small intestine of AhR-
deficient mice. However, we did not detect 
changes in expression of genes from the KGF 
pathway, which supports gut barrier integrity. 
We think this reflects that  T cells are not 
the major players in our OT model. This may 
be different for models of food allergy, which 
use cholera toxin as an “adjuvant” to induce 
an immune response against the fed peptide 
antigen. Thus, it was shown recently that gut 
 T cells (but not conventional  T cells) 
take up cholera toxin, and subsequently mi-
grate to the lamina propria, where they se-
creted IL10 and IL17. The authors conclude 
that gutT cells may have a major role in 
food allergy (Frossard et al., 2015).  
Breeding lck-Cre transgenic mice to AhR-
flox/flox mice, we deleted AhR in T cells. Lck is 
expressed in all T cells once they begin their 
differentiation in the thymus. The lck-directed 
Cre-recombinase expression did not delete 
AhR in intraepithelial  cells. This was en-
tirely unexpected and is currently under fur-
ther investigation. However, the phenomenon 
allowed us to distinguish the effect of AhR-
ablated conventional T cells from T cells. 
In thelck mice, OT was impaired upon sev-
eral immunizations. Also, in lck mice, the 
T cells were as abundant as in WT litter-
mate controls, in which tolerance did not 
break. This reinforces our reasoning above 
that intestinal  T cells are not critical in our 
model of OT stability challenge. Mice with an 
ablation of AhR in intestinal epithelial cells 
and DC remained tolerant despite four im-
munizations. Together this data shows the im-
portance of (conventional) T cells in main-
taining oral tolerance. Note though, that we 
could not detect gross changes in CD4+ and 
Treg cell subset frequencies in AhR-deficient 
mice. Obviously, as simple changes in fre-
quencies were inconclusive. Further, and 
more complex, analyses are needed to iden-
tify the respective contribution of T cell sub-
sets. 
AhR-deficiency leads not only to loss 
of T cells in the gut and skin, but also to a 
failure of innate lymphoid cells ILC3 to de-
velop in the gut (Kiss et al., 2011). The con-
sequences are high bacterial loads in the gut, 
and susceptibility to the gut pathogen 
Citrobacter rodentium, due to the failure to 
produce the protective AhR-dependent cyto-
kine IL22 (Kiss et al., 2011; Monteleone et 
al., 2011). The role of changes in the microbi-
ome by AhR, which might be associated with 
the changes in bacterial loads, remains to be 
further explored. Strikingly, it was shown that 
the removal of AhR-ligands from the diet 
EXCLI Journal 2017;16:291-301 – ISSN 1611-2156 
Received: January 23, 2017, accepted: March 04, 2017, published: March 20, 2017 
 
 
299 
phenocopied the AhR-deficient mice. Moreo-
ver, re-addition of a single AhR-ligand pre-
cursor (indole-3-carbinol) into the diet res-
cued the phenotype (Kiss et al., 2011; Li et al., 
2011). The data of these studies made a strong 
point for the need for a vegetable-containing 
diet; indeed it provided a molecular mecha-
nism how certain plant compounds such as 
glucosinolates or flavonoids improve gut 
health. In similar approaches regarding skin 
barrier, we also found that an AhR-ligand-de-
ficient diet impairs the skin barrier similar to 
AhR-deficiency (Haas et al., 2016). We there-
fore fed an AhR-ligand-deficient diet for three 
weeks before inducing OT. Unfortunately, us-
ing our oral tolerance protocol, we could not 
mimic the effect of AhR-deficiency (data not 
shown). While this finding was disappointing, 
it is possible that non-dietary AhR ligands 
were present in the mice, e.g. those formed by 
gut bacteria, or via endogenous generation 
(Esser and Rannug, 2015). These ligands then 
would be sufficient for AhR-activity in sup-
porting oral tolerance. In other words, OT 
may be less sensitive to low levels of dietary 
ligands than the postnatal generation or pro-
liferation of ILC3 or T cells in the gut. A 
more trivial explanation is that the feeding 
had not been long enough. We do not think 
this is likely, though, as for reduction of  T 
cells in the gut, dietary intervention of three 
weeks had been sufficient (Li et al., 2011). 
Even the skin barrier was affected after two 
weeks of AhR-ligand-deficient diet (personal 
communication K. Haas). 
It is noteworthy in this context, that the 
antibody titers indicating break of OT were 
low in absolute terms. Would this matter 
when considering break of OT as a prerequi-
site for food allergy? It is well known that the 
immune system is very flexible and individual 
variation in many immune parameters can be 
high. Only once a certain threshold is passed, 
an adverse outcome ensues. However, we 
agree with the idea of Hartung and Corsini 
(2013) who pointed out that the closer an in-
dividual is to that threshold of adversity, the 
easier it is for any added environmental fac-
tors (e.g., diet, stress) to push it „over the 
edge“. Prevention could thus aim at moving 
the immune system away from the danger 
zone. In our case, this might be achieved by 
keeping AhR signaling in the gut in the bal-
ance. Some epidemiological evidence, which 
identified correlations between healthy diet 
and low allergy risks, underlines this thinking 
(Grimshaw et al., 2014).  
In conclusion, AhR expression at least in 
T cells is necessary for stabilizing OT in mice, 
stressing again the importance of this mole-
cule for mucosal immunity. 
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